Arcus Development Group Stock
Your prediction
Pros and Cons of Arcus Development Group in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Arcus Development Group vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Arcus Development Group | - | - | - | - | - | - | - |
| Nevada Sunrise Metals Corp. | -1.920% | -8.929% | -21.538% | 131.818% | 131.818% | -80.385% | -53.211% |
| Orla Mining Ltd | 3.320% | 4.892% | 6.903% | 108.411% | 110.179% | 208.864% | 170.631% |
| Trailbreaker Resources Ltd. | -8.700% | -16.556% | -19.231% | -30.769% | -25.882% | 154.545% | -14.865% |
News
Arcus Biosciences President Sells $2 Million in Stock Under Trading Plan
Juan C. Jaen, the president of Arcus Biosciences (NYSE:RCUS), sold 96,859 shares in multiple open-market transactions on Tuesday and Wednesday, according to an SEC Form 4 filing.
The transaction
Arcus (RCUS) Q2 Revenue Jumps 310%
Arcus Biosciences (NYSE:RCUS), a clinical-stage biotech focused on cancer immunotherapies, reported its second-quarter 2025 earnings on August 6, 2025. GAAP revenue and earnings per share both